Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Sexual Dysfunction, Physiological 1Rectal Neoplasms 1Intestinal Diseases 1

Interventions

alvimopan 5Surveys and Questionnaires 2Cyclophosphamide 2pralsetinib 1pembrolizumab 1napabucasin 1guadecitabine 1Ursodeoxycholic Acid 1Surgical Procedures, Operative 1Pemetrexed 1Oxaliplatin 1Oviposition 1Ocoxin 1Low Density Lipoprotein Receptor-Related Protein-1 1Leucovorin 1Irinotecan 1Fluorouracil 1Exercise 1Drainage 1Colonoscopy 1Cetuximab 1Celecoxib 1Capecitabine 1Calcium Dobesilate 1Bupivacaine 1Bevacizumab 15-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 15,10-methylenetetrahydrofolic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Intestinal Diseases × Low Density Lipoprotein Receptor-Related Protein-1 × Clear all
NCT04134104 2023-11-13

Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal Malignancy

National Academy of Medical Sciences, Nepal

Completed
38 enrolled
Other

Intestinal Diseases, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡